Status:
COMPLETED
Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
Lead Sponsor:
Gynuity Health Projects
Conditions:
Induced Abortion
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of sublingual misoprostol (i.e., under the tongue) taken 24 hours following administration of mifepristone 2...
Eligibility Criteria
Inclusion
- Women presenting for medical abortion who consent to participate
- Possibility of final gestational age of less than or equal to 63 days
- General good health
- Willing to provide contact information for purposes of follow-up
Exclusion
- Conditions which contraindicate the use of mifepristone or misoprostol
- Women presenting for medical abortion who do not consent to participate
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
1443 Patients enrolled
Trial Details
Trial ID
NCT00286208
Start Date
August 1 2005
End Date
January 1 2008
Last Update
February 19 2014
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of Medicine and Pharmacy
Chisinau, Moldova
2
Centre de Planification Familiale de l'Ariana
Aryanah, Tunisia
3
Centre de Planification Familiale la Bardo
Tunis, Tunisia
4
Maternité de La Rabta
Tunis, Tunisia